Overview


According to FutureWise analysis, the market for Alopecia Drug is expected to grow at a CAGR of 9.70% over the forecast period of 2023-2031.

Alopecia is a term used in medicine that describes hair loss or baldness. It can affect both men and women and occur in the scalp or other parts of the body; known as male-pattern baldness and female-pattern baldness. Male pattern baldness is the most prevalent type of alopecia, affecting approximately 50% of men by the time they reach 50 years of age; it is known as androgenetic alopecia, male-pattern baldness, or androgenic alopecia. This hereditary condition is linked to an excess of a specific hormone, which negatively impacts hair follicles. The characteristic features include a receding hairline and overall thinning of hair. Typically, the onset of hair loss occurs during a man's late 20s or early 30s. Baldness can also impact women, referred to as female-pattern baldness. Unlike male-pattern baldness, the exact hereditary and causal factors for female-pattern baldness remain uncertain among scientists. However, it appears more common in post-menopausal women, suggesting a possible connection to hormonal changes during this stage of life.

Male-pattern baldness is a natural part of aging and usually doesn't require treatment for health reasons. However, it can cause distress and impact self-confidence. Finasteride and minoxidil are the choices of drugs used for treatment, but results are not guaranteed, and the effects are temporary. Alopecia areata can be best treated with steroids or immunotherapy to stimulate hair growth in bald areas. Hair transplants or implants are surgical options for treating alopecia, mainly male-pattern baldness. Wigs made of synthetic or natural hair are also available as alternatives. In scalp reduction surgery, bald areas are removed, and the surrounding hair-bearing skin is sewn together to cover the bald patch.

FutureWise Market Research has published a report that provides an insightful analysis of Alopecia Drug Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Alopecia Drug Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization

  • GlaxoSmithKline
  • Johnson & Johnson
  • Cipla Inc.
  • Dr. Reddy’s Laboratories Ltd
  • Merck
  • Aqua Pharmaceuticals
  • Bayer HealthCare
  • AndroScience
  • Helix BioMedix
  • The Himalaya Drug Company

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Alopecia Drug Market:

  • In March 2023, Sun Pharmaceuticals Industries Ltd., a global pharmaceutical company, announced the presentation of phase 3 clinical trial data for deuruxolitinib, an oral medicine to improve scalp hair regrowth in patients with alopecia areata.
  • In June 2023, Pfizer Inc., a multinational biotechnology and pharmaceutical company, revealed that the US Food and Drug Administration (FDA) had approved LITFULOTM (ritlecitinib), an oral treatment for severe alopecia areata in individuals aged 12 years and above. This approval positions LITFULOTM as an advanced treatment option for people suffering from alopecia areata.

The alopecia drugs (hair loss) market is witnessing growth due to the increasing prevalence of hair loss conditions, an aging population, and rising disposable income. As more individuals experience hair loss due to poor lifestyle habits and aging-related hormonal changes, the demand for effective treatments is growing. With its higher propensity for hair loss, the aging population represents a significant market segment driving the demand for treatment options. The growing emphasis on personal appearance and self-esteem has also led people to seek solutions for their hair loss concerns. Investments in research and development fuel innovation in the market, leading to the introduction of advanced treatment approaches, including stem cell therapies and regenerative medicine techniques.

However, the market also faces challenges, such as the high costs associated with specific treatments like hair transplants, limiting accessibility for some individuals. The limited effectiveness of treatments and potential side effects also impact market growth, as patients may be hesitant to invest in treatments with uncertain outcomes. Despite these challenges, technological advancements in treatments, such as hair transplant procedures and laser therapies, offer potential opportunities for market expansion. As companies focus on addressing these challenges and providing safe and effective treatments, the alopecia treatment market continues to grow and meet the demand for hair loss solution.

By Alopecia Types

  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
  • Others

By Route of Administration (ROA)

  • Oral
  • Topical
  • Injectable

By Gender

  • Men
  • Women

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. In 2022, North America held the most significant share in the alopecia treatment market, regional shares. This was primarily driven by several factors, including a high prevalence of the disease, increased awareness among consumers about alopecia, proactive measures taken by the government, improvements in healthcare infrastructure, and technological advancements. Moreover, the growing adoption of laser-based therapy for treating alopecia has increased the treatment rate in North America. Additionally, the presence of government and non-profit organizations like the National Alopecia Areata Foundation (NAAF) and the Canadian Alopecia Areata Foundation has played a crucial role in providing guidelines and creating awareness among people, thus positively impacting the market.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the of Alopecia Drug Market By Alopecia Types, By Route of Administration (ROA), By Gender and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represents in format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Alopecia Drugs Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Alopecia Drugs Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Alopecia Drugs Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Alopecia Drugs Market, By Alopecia Types Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Alopecia Areata
        2. Alopecia Totalis
        3. Alopecia Universalis
        4. Others

  • 8.   Global Alopecia Drugs Market, By Route of Administration (ROA) Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral
        2. Topical
        3. Injectable

  • 9.   Global Alopecia Drugs Market, By Gender Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Men
        2. Women

  • 10.   North America Alopecia Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Alopecia Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Alopecia Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         11.2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Alopecia Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Alopecia Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. GlaxoSmithKline
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Johnson and Johnson
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Cipla Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Dr. Reddy’s Laboratories Ltd
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Merck
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Aqua Pharmaceuticals
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Bayer HealthCare
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. AndroScience.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Helix BioMedix
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
         10. The Himalaya Drug Company
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Alopecia Treatment Market

Read More

Alopecia Market

Read More

Alopecia Areata Market

Read More
Partner

Our Clients